Stryker Corp. (NYSE:SYK) is believed by RBC Capital to be the company in it covers that will most likely issue a special dividend. The firm is convinced that the company may potentially issue a special dividend of $2.63 per share, and it keeps its Outperform rating on the stock.
Myriad Genetics Inc. (NASDAQ:MYGN): According to JMP Securities, the Supreme Court’s decision to hear the court case involving Myriad Genetics is likely to create a major overhang on the stock, especially since the firm believes that the outcome has the potential to keep the company from patenting genes in the future. The firm argues that a decision like this may potentially have negative implications on the company’s various vertical markets, and it keeps its Sector Perform rating on the stock.
Catalysts are critical to discovering winning stocks. Check out our newest CHEAT SHEET stock picks now.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX is believed by JMP Securities to have several “transformative catalysts” during 2013, and it keeps its Outperform rating and a $100 price target on the stock.
Lululemon Athletica Inc. (NASDAQ:LULU): Credit Suisse has stated that its checks suggest that lululemon’s Q3 showed solid demand and in-stock levels have shown a great deal of improvement. The firm continues to support the Q3 estimates, and it maintians its Outperform rating and $45 price target on the stock.
Don’t Miss: Can McDonald’s Find Value In Its Dollar Menu?